Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Inactive Non-infectious Uveitis
NCT01124838Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Aug 2010
- Primary completion
- May 2015
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of adalimumab in intermediate uveitis (IU), posterior uveitis, panuveitis, sponsored by AbbVie Inc.. Started Aug 2010; status: completed.
02
Drugs
03
Conditions
intermediate uveitis (IU)posterior uveitispanuveitis
Beyond the preview
Go deeper on NCT01124838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01124838.